These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21348588)
21. Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa mycobacterium tuberculosis secretory antigen. Natarajan K; Latchumanan VK; Singh B; Singh S; Sharma P J Infect Dis; 2003 Mar; 187(6):914-28. PubMed ID: 12660938 [TBL] [Abstract][Full Text] [Related]
22. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
23. Mouse and guinea pig models for testing new tuberculosis vaccines. Orme IM Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022 [TBL] [Abstract][Full Text] [Related]
26. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035 [TBL] [Abstract][Full Text] [Related]
27. Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine. Shanahan ER; Pinto R; Triccas JA; Britton WJ; West NP Vaccine; 2010 Feb; 28(5):1341-6. PubMed ID: 19941992 [TBL] [Abstract][Full Text] [Related]
28. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Griffiths KL; Ahmed M; Das S; Gopal R; Horne W; Connell TD; Moynihan KD; Kolls JK; Irvine DJ; Artyomov MN; Rangel-Moreno J; Khader SA Nat Commun; 2016 Dec; 7():13894. PubMed ID: 28004802 [TBL] [Abstract][Full Text] [Related]
29. Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes. García-Romo GS; Pedroza-González A; Aguilar-León D; Orozco-Estevez H; Lambrecht BN; Estrada-Garcia I; Flores-Romo L; Hernández-Pando R Immunology; 2004 Aug; 112(4):661-8. PubMed ID: 15270738 [TBL] [Abstract][Full Text] [Related]
30. Mycobacterium-specific human CD8 T cell responses. Klein MR; Fox A Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136 [TBL] [Abstract][Full Text] [Related]
31. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines. Mascart F; Locht C Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361 [TBL] [Abstract][Full Text] [Related]
32. [Dendritic cells of mucosa and skin: "recruited for vaccination"]. Le Borgne M; Dubois B; Kaiserlian D Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889 [TBL] [Abstract][Full Text] [Related]
33. gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis. Caccamo N; Sireci G; Meraviglia S; Dieli F; Ivanyi J; Salerno A Eur J Immunol; 2006 Oct; 36(10):2681-90. PubMed ID: 16981183 [TBL] [Abstract][Full Text] [Related]
35. Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosis. Talaat KR; Bonawitz RE; Domenech P; Nutman TB J Infect Dis; 2006 Jan; 193(2):196-204. PubMed ID: 16362883 [TBL] [Abstract][Full Text] [Related]
36. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. Liu Y; Huang H; Chen Z; Zong L; Xiang J J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636 [TBL] [Abstract][Full Text] [Related]
37. Aerosol vaccines for tuberculosis: a fine line between protection and pathology. Hokey DA; Misra A Tuberculosis (Edinb); 2011 Jan; 91(1):82-5. PubMed ID: 21067975 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445 [TBL] [Abstract][Full Text] [Related]
39. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses. Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943 [TBL] [Abstract][Full Text] [Related]
40. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis. Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]